nodes	percent_of_prediction	percent_of_DWPC	metapath
Methimazole—CYP2E1—Fingolimod—multiple sclerosis	0.162	0.189	CbGbCtD
Methimazole—CYP2A6—Prednisolone—multiple sclerosis	0.102	0.118	CbGbCtD
Methimazole—CYP2D6—Fingolimod—multiple sclerosis	0.0772	0.0899	CbGbCtD
Methimazole—CYP2E1—Mitoxantrone—multiple sclerosis	0.0762	0.0887	CbGbCtD
Methimazole—CYP2A6—Dexamethasone—multiple sclerosis	0.0599	0.0697	CbGbCtD
Methimazole—CYP3A4—Fingolimod—multiple sclerosis	0.0491	0.0572	CbGbCtD
Methimazole—CYP2C19—Prednisone—multiple sclerosis	0.0397	0.0462	CbGbCtD
Methimazole—CYP2E1—Dexamethasone—multiple sclerosis	0.0395	0.046	CbGbCtD
Methimazole—CYP2B6—Dexamethasone—multiple sclerosis	0.039	0.0454	CbGbCtD
Methimazole—CYP3A4—Methylprednisolone—multiple sclerosis	0.0316	0.0368	CbGbCtD
Methimazole—CYP2C19—Dexamethasone—multiple sclerosis	0.0248	0.0288	CbGbCtD
Methimazole—CYP3A4—Triamcinolone—multiple sclerosis	0.024	0.0279	CbGbCtD
Methimazole—CYP3A4—Mitoxantrone—multiple sclerosis	0.0231	0.0269	CbGbCtD
Methimazole—CYP2C9—Dexamethasone—multiple sclerosis	0.0206	0.024	CbGbCtD
Methimazole—CYP3A4—Betamethasone—multiple sclerosis	0.0206	0.024	CbGbCtD
Methimazole—CYP3A4—Prednisolone—multiple sclerosis	0.0203	0.0236	CbGbCtD
Methimazole—CYP3A4—Prednisone—multiple sclerosis	0.0192	0.0223	CbGbCtD
Methimazole—CYP2D6—Dexamethasone—multiple sclerosis	0.0188	0.0219	CbGbCtD
Methimazole—CYP3A4—Dexamethasone—multiple sclerosis	0.012	0.0139	CbGbCtD
Methimazole—Pigmentation skin—Prednisone—multiple sclerosis	0.00525	0.0514	CcSEcCtD
Methimazole—Neuritis—Cladribine—multiple sclerosis	0.00328	0.0321	CcSEcCtD
Methimazole—Pigmentation disorder—Prednisone—multiple sclerosis	0.00287	0.0281	CcSEcCtD
Methimazole—Aplastic anaemia—Cladribine—multiple sclerosis	0.0023	0.0225	CcSEcCtD
Methimazole—Alopecia—Fingolimod—multiple sclerosis	0.00192	0.0187	CcSEcCtD
Methimazole—Aplastic anaemia—Azathioprine—multiple sclerosis	0.00187	0.0183	CcSEcCtD
Methimazole—Neuritis—Prednisolone—multiple sclerosis	0.00177	0.0173	CcSEcCtD
Methimazole—Leukopenia—Fingolimod—multiple sclerosis	0.00169	0.0165	CcSEcCtD
Methimazole—Neuritis—Triamcinolone—multiple sclerosis	0.00163	0.0159	CcSEcCtD
Methimazole—Neuritis—Methylprednisolone—multiple sclerosis	0.00162	0.0159	CcSEcCtD
Methimazole—Neuritis—Dexamethasone—multiple sclerosis	0.00148	0.0144	CcSEcCtD
Methimazole—Neuritis—Betamethasone—multiple sclerosis	0.00148	0.0144	CcSEcCtD
Methimazole—TPO—Amino acid and derivative metabolism—SRM—multiple sclerosis	0.00139	0.036	CbGpPWpGaD
Methimazole—Paraesthesia—Fingolimod—multiple sclerosis	0.00138	0.0135	CcSEcCtD
Methimazole—Neuritis—Prednisone—multiple sclerosis	0.00128	0.0126	CcSEcCtD
Methimazole—Pruritus—Fingolimod—multiple sclerosis	0.00109	0.0107	CcSEcCtD
Methimazole—Alopecia—Cladribine—multiple sclerosis	0.00109	0.0106	CcSEcCtD
Methimazole—Agranulocytosis—Azathioprine—multiple sclerosis	0.00104	0.0102	CcSEcCtD
Methimazole—Headache—Fingolimod—multiple sclerosis	0.000965	0.00944	CcSEcCtD
Methimazole—Myalgia—Cladribine—multiple sclerosis	0.000911	0.00891	CcSEcCtD
Methimazole—Arthralgia—Cladribine—multiple sclerosis	0.000911	0.00891	CcSEcCtD
Methimazole—Drowsiness—Mitoxantrone—multiple sclerosis	0.0009	0.0088	CcSEcCtD
Methimazole—Alopecia—Azathioprine—multiple sclerosis	0.000883	0.00864	CcSEcCtD
Methimazole—Jaundice—Mitoxantrone—multiple sclerosis	0.000877	0.00858	CcSEcCtD
Methimazole—Oedema—Cladribine—multiple sclerosis	0.000873	0.00854	CcSEcCtD
Methimazole—Thrombocytopenia—Cladribine—multiple sclerosis	0.000855	0.00836	CcSEcCtD
Methimazole—Agranulocytosis—Mitoxantrone—multiple sclerosis	0.00084	0.00822	CcSEcCtD
Methimazole—Hepatitis—Mitoxantrone—multiple sclerosis	0.000808	0.0079	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Cladribine—multiple sclerosis	0.000796	0.00778	CcSEcCtD
Methimazole—Paraesthesia—Cladribine—multiple sclerosis	0.000784	0.00767	CcSEcCtD
Methimazole—Leukopenia—Azathioprine—multiple sclerosis	0.000779	0.00762	CcSEcCtD
Methimazole—Somnolence—Cladribine—multiple sclerosis	0.000776	0.00759	CcSEcCtD
Methimazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000755	0.0195	CbGpPWpGaD
Methimazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000755	0.0195	CbGpPWpGaD
Methimazole—Aplastic anaemia—Methotrexate—multiple sclerosis	0.000753	0.00736	CcSEcCtD
Methimazole—Myalgia—Azathioprine—multiple sclerosis	0.000741	0.00725	CcSEcCtD
Methimazole—Arthralgia—Azathioprine—multiple sclerosis	0.000741	0.00725	CcSEcCtD
Methimazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00074	0.0191	CbGpPWpGaD
Methimazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00074	0.0191	CbGpPWpGaD
Methimazole—CYP2A6—Fluoropyrimidine Activity—RRM1—multiple sclerosis	0.000727	0.0188	CbGpPWpGaD
Methimazole—Neuropathy peripheral—Prednisolone—multiple sclerosis	0.000724	0.00708	CcSEcCtD
Methimazole—Alopecia—Mitoxantrone—multiple sclerosis	0.000714	0.00698	CcSEcCtD
Methimazole—Thrombocytopenia—Azathioprine—multiple sclerosis	0.000695	0.0068	CcSEcCtD
Methimazole—Urticaria—Cladribine—multiple sclerosis	0.000694	0.00679	CcSEcCtD
Methimazole—Body temperature increased—Cladribine—multiple sclerosis	0.00069	0.00675	CcSEcCtD
Methimazole—Lymphadenopathy—Methotrexate—multiple sclerosis	0.000682	0.00667	CcSEcCtD
Methimazole—Neuropathy peripheral—Triamcinolone—multiple sclerosis	0.000666	0.00651	CcSEcCtD
Methimazole—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	0.000664	0.0065	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	0.000647	0.00633	CcSEcCtD
Methimazole—Leukopenia—Mitoxantrone—multiple sclerosis	0.00063	0.00616	CcSEcCtD
Methimazole—Pruritus—Cladribine—multiple sclerosis	0.000618	0.00604	CcSEcCtD
Methimazole—Neuropathy peripheral—Betamethasone—multiple sclerosis	0.000604	0.00591	CcSEcCtD
Methimazole—Neuropathy peripheral—Dexamethasone—multiple sclerosis	0.000604	0.00591	CcSEcCtD
Methimazole—Myalgia—Mitoxantrone—multiple sclerosis	0.000599	0.00586	CcSEcCtD
Methimazole—Arthralgia—Mitoxantrone—multiple sclerosis	0.000599	0.00586	CcSEcCtD
Methimazole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000594	0.0154	CbGpPWpGaD
Methimazole—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000594	0.0154	CbGpPWpGaD
Methimazole—CYP2A6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000586	0.0152	CbGpPWpGaD
Methimazole—CYP2A6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000586	0.0152	CbGpPWpGaD
Methimazole—Oedema—Mitoxantrone—multiple sclerosis	0.000574	0.00562	CcSEcCtD
Methimazole—TPO—Hematopoietic Stem Cell Differentiation—IL1B—multiple sclerosis	0.000566	0.0146	CbGpPWpGaD
Methimazole—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000562	0.0055	CcSEcCtD
Methimazole—Body temperature increased—Azathioprine—multiple sclerosis	0.000561	0.00549	CcSEcCtD
Methimazole—Vomiting—Cladribine—multiple sclerosis	0.000555	0.00543	CcSEcCtD
Methimazole—Rash—Cladribine—multiple sclerosis	0.000551	0.00539	CcSEcCtD
Methimazole—Dermatitis—Cladribine—multiple sclerosis	0.00055	0.00538	CcSEcCtD
Methimazole—Headache—Cladribine—multiple sclerosis	0.000547	0.00535	CcSEcCtD
Methimazole—Neuropathy peripheral—Prednisone—multiple sclerosis	0.000526	0.00514	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000523	0.00512	CcSEcCtD
Methimazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00052	0.0134	CbGpPWpGaD
Methimazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00052	0.0134	CbGpPWpGaD
Methimazole—Nausea—Cladribine—multiple sclerosis	0.000519	0.00507	CcSEcCtD
Methimazole—Vertigo—Prednisolone—multiple sclerosis	0.000518	0.00507	CcSEcCtD
Methimazole—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000515	0.00504	CcSEcCtD
Methimazole—Somnolence—Mitoxantrone—multiple sclerosis	0.00051	0.00499	CcSEcCtD
Methimazole—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000505	0.00494	CcSEcCtD
Methimazole—Alopecia—Dexamethasone—multiple sclerosis	0.000489	0.00478	CcSEcCtD
Methimazole—Alopecia—Betamethasone—multiple sclerosis	0.000489	0.00478	CcSEcCtD
Methimazole—CYP2A6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000482	0.0124	CbGpPWpGaD
Methimazole—CYP2A6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000482	0.0124	CbGpPWpGaD
Methimazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000479	0.0124	CbGpPWpGaD
Methimazole—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000479	0.0124	CbGpPWpGaD
Methimazole—Vertigo—Triamcinolone—multiple sclerosis	0.000477	0.00466	CcSEcCtD
Methimazole—Vertigo—Methylprednisolone—multiple sclerosis	0.000476	0.00465	CcSEcCtD
Methimazole—CYP2B6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000473	0.0122	CbGpPWpGaD
Methimazole—CYP2B6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000473	0.0122	CbGpPWpGaD
Methimazole—Oedema—Prednisolone—multiple sclerosis	0.000471	0.00461	CcSEcCtD
Methimazole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00047	0.0121	CbGpPWpGaD
Methimazole—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00047	0.0121	CbGpPWpGaD
Methimazole—CYP2E1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000463	0.012	CbGpPWpGaD
Methimazole—CYP2E1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000463	0.012	CbGpPWpGaD
Methimazole—Urticaria—Mitoxantrone—multiple sclerosis	0.000456	0.00446	CcSEcCtD
Methimazole—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000454	0.00444	CcSEcCtD
Methimazole—Myalgia—Triamcinolone—multiple sclerosis	0.000452	0.00442	CcSEcCtD
Methimazole—Vomiting—Azathioprine—multiple sclerosis	0.000451	0.00442	CcSEcCtD
Methimazole—Arthralgia—Methylprednisolone—multiple sclerosis	0.000451	0.00441	CcSEcCtD
Methimazole—Myalgia—Methylprednisolone—multiple sclerosis	0.000451	0.00441	CcSEcCtD
Methimazole—Drowsiness—Methotrexate—multiple sclerosis	0.000448	0.00439	CcSEcCtD
Methimazole—Rash—Azathioprine—multiple sclerosis	0.000448	0.00438	CcSEcCtD
Methimazole—Dermatitis—Azathioprine—multiple sclerosis	0.000447	0.00438	CcSEcCtD
Methimazole—Headache—Azathioprine—multiple sclerosis	0.000445	0.00435	CcSEcCtD
Methimazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000445	0.0115	CbGpPWpGaD
Methimazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000445	0.0115	CbGpPWpGaD
Methimazole—Oedema—Triamcinolone—multiple sclerosis	0.000433	0.00424	CcSEcCtD
Methimazole—Vertigo—Dexamethasone—multiple sclerosis	0.000433	0.00423	CcSEcCtD
Methimazole—Vertigo—Betamethasone—multiple sclerosis	0.000433	0.00423	CcSEcCtD
Methimazole—Alopecia—Prednisone—multiple sclerosis	0.000426	0.00416	CcSEcCtD
Methimazole—Paraesthesia—Prednisolone—multiple sclerosis	0.000423	0.00414	CcSEcCtD
Methimazole—Nausea—Azathioprine—multiple sclerosis	0.000422	0.00413	CcSEcCtD
Methimazole—Agranulocytosis—Methotrexate—multiple sclerosis	0.000418	0.00409	CcSEcCtD
Methimazole—Myalgia—Betamethasone—multiple sclerosis	0.00041	0.00401	CcSEcCtD
Methimazole—Myalgia—Dexamethasone—multiple sclerosis	0.00041	0.00401	CcSEcCtD
Methimazole—Hepatitis—Methotrexate—multiple sclerosis	0.000403	0.00394	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000395	0.00386	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000394	0.00385	CcSEcCtD
Methimazole—Oedema—Dexamethasone—multiple sclerosis	0.000393	0.00384	CcSEcCtD
Methimazole—Oedema—Betamethasone—multiple sclerosis	0.000393	0.00384	CcSEcCtD
Methimazole—Paraesthesia—Triamcinolone—multiple sclerosis	0.000389	0.0038	CcSEcCtD
Methimazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000389	0.01	CbGpPWpGaD
Methimazole—CYP2B6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000389	0.01	CbGpPWpGaD
Methimazole—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000388	0.0038	CcSEcCtD
Methimazole—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000385	0.00376	CcSEcCtD
Methimazole—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000385	0.00376	CcSEcCtD
Methimazole—Dyspepsia—Triamcinolone—multiple sclerosis	0.000381	0.00373	CcSEcCtD
Methimazole—CYP2E1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000381	0.00984	CbGpPWpGaD
Methimazole—CYP2E1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000381	0.00984	CbGpPWpGaD
Methimazole—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00038	0.00372	CcSEcCtD
Methimazole—TPO—Differentiation Pathway—TGFB1—multiple sclerosis	0.00038	0.00981	CbGpPWpGaD
Methimazole—Vertigo—Prednisone—multiple sclerosis	0.000377	0.00369	CcSEcCtD
Methimazole—Urticaria—Prednisolone—multiple sclerosis	0.000374	0.00366	CcSEcCtD
Methimazole—Vomiting—Mitoxantrone—multiple sclerosis	0.000365	0.00357	CcSEcCtD
Methimazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000362	0.00936	CbGpPWpGaD
Methimazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000362	0.00936	CbGpPWpGaD
Methimazole—Rash—Mitoxantrone—multiple sclerosis	0.000362	0.00354	CcSEcCtD
Methimazole—Dermatitis—Mitoxantrone—multiple sclerosis	0.000362	0.00354	CcSEcCtD
Methimazole—Headache—Mitoxantrone—multiple sclerosis	0.00036	0.00352	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000358	0.0035	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000358	0.0035	CcSEcCtD
Methimazole—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000358	0.00924	CbGpPWpGaD
Methimazole—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000358	0.00924	CbGpPWpGaD
Methimazole—Arthralgia—Prednisone—multiple sclerosis	0.000357	0.00349	CcSEcCtD
Methimazole—Myalgia—Prednisone—multiple sclerosis	0.000357	0.00349	CcSEcCtD
Methimazole—Alopecia—Methotrexate—multiple sclerosis	0.000356	0.00348	CcSEcCtD
Methimazole—Paraesthesia—Betamethasone—multiple sclerosis	0.000353	0.00345	CcSEcCtD
Methimazole—Paraesthesia—Dexamethasone—multiple sclerosis	0.000353	0.00345	CcSEcCtD
Methimazole—Dyspepsia—Dexamethasone—multiple sclerosis	0.000346	0.00338	CcSEcCtD
Methimazole—Dyspepsia—Betamethasone—multiple sclerosis	0.000346	0.00338	CcSEcCtD
Methimazole—Urticaria—Triamcinolone—multiple sclerosis	0.000344	0.00337	CcSEcCtD
Methimazole—Urticaria—Methylprednisolone—multiple sclerosis	0.000343	0.00336	CcSEcCtD
Methimazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000343	0.00887	CbGpPWpGaD
Methimazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000343	0.00887	CbGpPWpGaD
Methimazole—Body temperature increased—Triamcinolone—multiple sclerosis	0.000342	0.00335	CcSEcCtD
Methimazole—Oedema—Prednisone—multiple sclerosis	0.000342	0.00335	CcSEcCtD
Methimazole—Nausea—Mitoxantrone—multiple sclerosis	0.000341	0.00334	CcSEcCtD
Methimazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000333	0.00861	CbGpPWpGaD
Methimazole—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000333	0.00861	CbGpPWpGaD
Methimazole—TPO—Hematopoietic Stem Cell Differentiation—IL6—multiple sclerosis	0.000331	0.00856	CbGpPWpGaD
Methimazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00033	0.00854	CbGpPWpGaD
Methimazole—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00033	0.00854	CbGpPWpGaD
Methimazole—CYP2D6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000329	0.0085	CbGpPWpGaD
Methimazole—CYP2D6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000329	0.0085	CbGpPWpGaD
Methimazole—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000326	0.00842	CbGpPWpGaD
Methimazole—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000326	0.00842	CbGpPWpGaD
Methimazole—Vertigo—Methotrexate—multiple sclerosis	0.000315	0.00308	CcSEcCtD
Methimazole—Leukopenia—Methotrexate—multiple sclerosis	0.000314	0.00307	CcSEcCtD
Methimazole—Urticaria—Betamethasone—multiple sclerosis	0.000312	0.00305	CcSEcCtD
Methimazole—Urticaria—Dexamethasone—multiple sclerosis	0.000312	0.00305	CcSEcCtD
Methimazole—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000312	0.00305	CcSEcCtD
Methimazole—Body temperature increased—Betamethasone—multiple sclerosis	0.000311	0.00304	CcSEcCtD
Methimazole—Body temperature increased—Dexamethasone—multiple sclerosis	0.000311	0.00304	CcSEcCtD
Methimazole—Paraesthesia—Prednisone—multiple sclerosis	0.000307	0.00301	CcSEcCtD
Methimazole—Pruritus—Triamcinolone—multiple sclerosis	0.000306	0.003	CcSEcCtD
Methimazole—Pruritus—Methylprednisolone—multiple sclerosis	0.000306	0.00299	CcSEcCtD
Methimazole—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000304	0.00785	CbGpPWpGaD
Methimazole—Dyspepsia—Prednisone—multiple sclerosis	0.000301	0.00295	CcSEcCtD
Methimazole—Myalgia—Methotrexate—multiple sclerosis	0.000298	0.00292	CcSEcCtD
Methimazole—Arthralgia—Methotrexate—multiple sclerosis	0.000298	0.00292	CcSEcCtD
Methimazole—Rash—Prednisolone—multiple sclerosis	0.000297	0.0029	CcSEcCtD
Methimazole—Dermatitis—Prednisolone—multiple sclerosis	0.000297	0.0029	CcSEcCtD
Methimazole—Headache—Prednisolone—multiple sclerosis	0.000295	0.00289	CcSEcCtD
Methimazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000294	0.00759	CbGpPWpGaD
Methimazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000294	0.00759	CbGpPWpGaD
Methimazole—TPO—Differentiation Pathway—IL6—multiple sclerosis	0.000286	0.0074	CbGpPWpGaD
Methimazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000282	0.00729	CbGpPWpGaD
Methimazole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000282	0.00729	CbGpPWpGaD
Methimazole—Thrombocytopenia—Methotrexate—multiple sclerosis	0.00028	0.00274	CcSEcCtD
Methimazole—Nausea—Prednisolone—multiple sclerosis	0.00028	0.00274	CcSEcCtD
Methimazole—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000279	0.0072	CbGpPWpGaD
Methimazole—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000279	0.0072	CbGpPWpGaD
Methimazole—Pruritus—Dexamethasone—multiple sclerosis	0.000278	0.00272	CcSEcCtD
Methimazole—Pruritus—Betamethasone—multiple sclerosis	0.000278	0.00272	CcSEcCtD
Methimazole—Vomiting—Triamcinolone—multiple sclerosis	0.000275	0.00269	CcSEcCtD
Methimazole—Vomiting—Methylprednisolone—multiple sclerosis	0.000275	0.00269	CcSEcCtD
Methimazole—Rash—Triamcinolone—multiple sclerosis	0.000273	0.00267	CcSEcCtD
Methimazole—Dermatitis—Triamcinolone—multiple sclerosis	0.000273	0.00267	CcSEcCtD
Methimazole—Rash—Methylprednisolone—multiple sclerosis	0.000272	0.00267	CcSEcCtD
Methimazole—Dermatitis—Methylprednisolone—multiple sclerosis	0.000272	0.00266	CcSEcCtD
Methimazole—Urticaria—Prednisone—multiple sclerosis	0.000272	0.00266	CcSEcCtD
Methimazole—Headache—Triamcinolone—multiple sclerosis	0.000271	0.00265	CcSEcCtD
Methimazole—Headache—Methylprednisolone—multiple sclerosis	0.000271	0.00265	CcSEcCtD
Methimazole—Body temperature increased—Prednisone—multiple sclerosis	0.00027	0.00265	CcSEcCtD
Methimazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.00027	0.00698	CbGpPWpGaD
Methimazole—CYP2D6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.00027	0.00698	CbGpPWpGaD
Methimazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000268	0.00692	CbGpPWpGaD
Methimazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000268	0.00692	CbGpPWpGaD
Methimazole—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000261	0.00255	CcSEcCtD
Methimazole—Nausea—Triamcinolone—multiple sclerosis	0.000257	0.00252	CcSEcCtD
Methimazole—Paraesthesia—Methotrexate—multiple sclerosis	0.000257	0.00251	CcSEcCtD
Methimazole—Nausea—Methylprednisolone—multiple sclerosis	0.000257	0.00251	CcSEcCtD
Methimazole—TPO—Metabolism—SRM—multiple sclerosis	0.000256	0.00662	CbGpPWpGaD
Methimazole—CYP2A6—Biological oxidations—CYP27B1—multiple sclerosis	0.000256	0.00661	CbGpPWpGaD
Methimazole—CYP2A6—Biological oxidations—CYP24A1—multiple sclerosis	0.000256	0.00661	CbGpPWpGaD
Methimazole—Somnolence—Methotrexate—multiple sclerosis	0.000254	0.00249	CcSEcCtD
Methimazole—Dyspepsia—Methotrexate—multiple sclerosis	0.000252	0.00246	CcSEcCtD
Methimazole—Vomiting—Betamethasone—multiple sclerosis	0.00025	0.00244	CcSEcCtD
Methimazole—Vomiting—Dexamethasone—multiple sclerosis	0.00025	0.00244	CcSEcCtD
Methimazole—Rash—Dexamethasone—multiple sclerosis	0.000248	0.00242	CcSEcCtD
Methimazole—Rash—Betamethasone—multiple sclerosis	0.000248	0.00242	CcSEcCtD
Methimazole—Dermatitis—Betamethasone—multiple sclerosis	0.000248	0.00242	CcSEcCtD
Methimazole—Dermatitis—Dexamethasone—multiple sclerosis	0.000248	0.00242	CcSEcCtD
Methimazole—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000247	0.00638	CbGpPWpGaD
Methimazole—Headache—Betamethasone—multiple sclerosis	0.000246	0.00241	CcSEcCtD
Methimazole—Headache—Dexamethasone—multiple sclerosis	0.000246	0.00241	CcSEcCtD
Methimazole—Pruritus—Prednisone—multiple sclerosis	0.000242	0.00237	CcSEcCtD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000242	0.00625	CbGpPWpGaD
Methimazole—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000242	0.00625	CbGpPWpGaD
Methimazole—Nausea—Dexamethasone—multiple sclerosis	0.000233	0.00228	CcSEcCtD
Methimazole—Nausea—Betamethasone—multiple sclerosis	0.000233	0.00228	CcSEcCtD
Methimazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000229	0.00591	CbGpPWpGaD
Methimazole—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000229	0.00591	CbGpPWpGaD
Methimazole—Urticaria—Methotrexate—multiple sclerosis	0.000227	0.00222	CcSEcCtD
Methimazole—Body temperature increased—Methotrexate—multiple sclerosis	0.000226	0.00221	CcSEcCtD
Methimazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000218	0.00563	CbGpPWpGaD
Methimazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000218	0.00563	CbGpPWpGaD
Methimazole—Vomiting—Prednisone—multiple sclerosis	0.000218	0.00213	CcSEcCtD
Methimazole—Rash—Prednisone—multiple sclerosis	0.000216	0.00211	CcSEcCtD
Methimazole—Dermatitis—Prednisone—multiple sclerosis	0.000216	0.00211	CcSEcCtD
Methimazole—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000215	0.00556	CbGpPWpGaD
Methimazole—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000215	0.00556	CbGpPWpGaD
Methimazole—Headache—Prednisone—multiple sclerosis	0.000214	0.0021	CcSEcCtD
Methimazole—CYP2B6—Biological oxidations—CYP24A1—multiple sclerosis	0.000206	0.00533	CbGpPWpGaD
Methimazole—CYP2B6—Biological oxidations—CYP27B1—multiple sclerosis	0.000206	0.00533	CbGpPWpGaD
Methimazole—CYP2B6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000204	0.00526	CbGpPWpGaD
Methimazole—CYP2B6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000204	0.00526	CbGpPWpGaD
Methimazole—Nausea—Prednisone—multiple sclerosis	0.000203	0.00199	CcSEcCtD
Methimazole—Pruritus—Methotrexate—multiple sclerosis	0.000202	0.00198	CcSEcCtD
Methimazole—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	0.000202	0.00522	CbGpPWpGaD
Methimazole—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	0.000202	0.00522	CbGpPWpGaD
Methimazole—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000199	0.00515	CbGpPWpGaD
Methimazole—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000199	0.00515	CbGpPWpGaD
Methimazole—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000195	0.00505	CbGpPWpGaD
Methimazole—Vomiting—Methotrexate—multiple sclerosis	0.000182	0.00178	CcSEcCtD
Methimazole—TPO—Metabolism—CYP27B1—multiple sclerosis	0.00018	0.00466	CbGpPWpGaD
Methimazole—TPO—Metabolism—CYP24A1—multiple sclerosis	0.00018	0.00466	CbGpPWpGaD
Methimazole—Rash—Methotrexate—multiple sclerosis	0.00018	0.00176	CcSEcCtD
Methimazole—Dermatitis—Methotrexate—multiple sclerosis	0.00018	0.00176	CcSEcCtD
Methimazole—Headache—Methotrexate—multiple sclerosis	0.000179	0.00175	CcSEcCtD
Methimazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000177	0.00456	CbGpPWpGaD
Methimazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000177	0.00456	CbGpPWpGaD
Methimazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.00017	0.0044	CbGpPWpGaD
Methimazole—Nausea—Methotrexate—multiple sclerosis	0.00017	0.00166	CcSEcCtD
Methimazole—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	0.00017	0.00439	CbGpPWpGaD
Methimazole—TPO—Metabolism—GPC5—multiple sclerosis	0.000165	0.00426	CbGpPWpGaD
Methimazole—CYP2D6—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000156	0.00403	CbGpPWpGaD
Methimazole—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	0.000156	0.00403	CbGpPWpGaD
Methimazole—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	0.000156	0.00403	CbGpPWpGaD
Methimazole—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000154	0.00398	CbGpPWpGaD
Methimazole—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000154	0.00398	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000152	0.00393	CbGpPWpGaD
Methimazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000145	0.00376	CbGpPWpGaD
Methimazole—CYP2D6—Biological oxidations—CYP24A1—multiple sclerosis	0.000144	0.00371	CbGpPWpGaD
Methimazole—CYP2D6—Biological oxidations—CYP27B1—multiple sclerosis	0.000144	0.00371	CbGpPWpGaD
Methimazole—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	0.000142	0.00368	CbGpPWpGaD
Methimazole—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	0.000142	0.00368	CbGpPWpGaD
Methimazole—CYP2D6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000142	0.00366	CbGpPWpGaD
Methimazole—CYP2D6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000142	0.00366	CbGpPWpGaD
Methimazole—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00014	0.00363	CbGpPWpGaD
Methimazole—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00014	0.00363	CbGpPWpGaD
Methimazole—TPO—Metabolism—RRM1—multiple sclerosis	0.000137	0.00353	CbGpPWpGaD
Methimazole—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.000134	0.00347	CbGpPWpGaD
Methimazole—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000134	0.00345	CbGpPWpGaD
Methimazole—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000132	0.00342	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000122	0.00314	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000122	0.00314	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.00012	0.0031	CbGpPWpGaD
Methimazole—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.00012	0.0031	CbGpPWpGaD
Methimazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000112	0.0029	CbGpPWpGaD
Methimazole—CYP2A6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000108	0.0028	CbGpPWpGaD
Methimazole—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000108	0.00279	CbGpPWpGaD
Methimazole—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000106	0.00273	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	9.38e-05	0.00242	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	9.38e-05	0.00242	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	9.25e-05	0.00239	CbGpPWpGaD
Methimazole—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	9.25e-05	0.00239	CbGpPWpGaD
Methimazole—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.74e-05	0.00226	CbGpPWpGaD
Methimazole—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	8.56e-05	0.00221	CbGpPWpGaD
Methimazole—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.15e-05	0.00211	CbGpPWpGaD
Methimazole—TPO—Metabolism—BCHE—multiple sclerosis	7.85e-05	0.00203	CbGpPWpGaD
Methimazole—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	7.8e-05	0.00201	CbGpPWpGaD
Methimazole—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.5e-05	0.00194	CbGpPWpGaD
Methimazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	7.43e-05	0.00192	CbGpPWpGaD
Methimazole—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.61e-05	0.00171	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	6.53e-05	0.00169	CbGpPWpGaD
Methimazole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	6.35e-05	0.00164	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—SRM—multiple sclerosis	6.21e-05	0.0016	CbGpPWpGaD
Methimazole—CYP2D6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.08e-05	0.00157	CbGpPWpGaD
Methimazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.02e-05	0.00156	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.99e-05	0.00155	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.99e-05	0.00155	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	5.83e-05	0.00151	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	5.81e-05	0.0015	CbGpPWpGaD
Methimazole—CYP2A6—Biological oxidations—POMC—multiple sclerosis	5.76e-05	0.00149	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	5.46e-05	0.00141	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	5.46e-05	0.00141	CbGpPWpGaD
Methimazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	5.15e-05	0.00133	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—SRM—multiple sclerosis	5.01e-05	0.00129	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—SRM—multiple sclerosis	4.91e-05	0.00127	CbGpPWpGaD
Methimazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.9e-05	0.00127	CbGpPWpGaD
Methimazole—TPO—Metabolism—APOE—multiple sclerosis	4.72e-05	0.00122	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	4.67e-05	0.00121	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	4.67e-05	0.00121	CbGpPWpGaD
Methimazole—CYP2B6—Biological oxidations—POMC—multiple sclerosis	4.64e-05	0.0012	CbGpPWpGaD
Methimazole—CYP2E1—Biological oxidations—POMC—multiple sclerosis	4.55e-05	0.00118	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	4.54e-05	0.00117	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	4.53e-05	0.00117	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	4.44e-05	0.00115	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	4.38e-05	0.00113	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	4.38e-05	0.00113	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	4.23e-05	0.00109	CbGpPWpGaD
Methimazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	4.23e-05	0.00109	CbGpPWpGaD
Methimazole—TPO—Metabolism—POMC—multiple sclerosis	4.06e-05	0.00105	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—GPC5—multiple sclerosis	4e-05	0.00103	CbGpPWpGaD
Methimazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.97e-05	0.00103	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—SRM—multiple sclerosis	3.79e-05	0.000978	CbGpPWpGaD
Methimazole—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	3.78e-05	0.000978	CbGpPWpGaD
Methimazole—TPO—Metabolism—ALB—multiple sclerosis	3.7e-05	0.000956	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	3.53e-05	0.000912	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	3.53e-05	0.000912	CbGpPWpGaD
Methimazole—CYP2C19—Biological oxidations—POMC—multiple sclerosis	3.51e-05	0.000907	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—SRM—multiple sclerosis	3.48e-05	0.0009	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	3.46e-05	0.000894	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	3.46e-05	0.000894	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—SRM—multiple sclerosis	3.45e-05	0.000892	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—RRM1—multiple sclerosis	3.32e-05	0.000857	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—GPC5—multiple sclerosis	3.23e-05	0.000834	CbGpPWpGaD
Methimazole—CYP2D6—Biological oxidations—POMC—multiple sclerosis	3.23e-05	0.000834	CbGpPWpGaD
Methimazole—CYP2C9—Biological oxidations—POMC—multiple sclerosis	3.2e-05	0.000827	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—GPC5—multiple sclerosis	3.16e-05	0.000817	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—SRM—multiple sclerosis	2.95e-05	0.000762	CbGpPWpGaD
Methimazole—CYP1A2—Biological oxidations—POMC—multiple sclerosis	2.73e-05	0.000707	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—RRM1—multiple sclerosis	2.68e-05	0.000691	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	2.67e-05	0.000689	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	2.67e-05	0.000689	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—RRM1—multiple sclerosis	2.62e-05	0.000677	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.61e-05	0.000674	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	2.45e-05	0.000634	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	2.45e-05	0.000634	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—GPC5—multiple sclerosis	2.44e-05	0.00063	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	2.43e-05	0.000629	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	2.43e-05	0.000629	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.38e-05	0.000614	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—SRM—multiple sclerosis	2.28e-05	0.000588	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—GPC5—multiple sclerosis	2.24e-05	0.00058	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—GPC5—multiple sclerosis	2.23e-05	0.000575	CbGpPWpGaD
Methimazole—CYP3A4—Biological oxidations—POMC—multiple sclerosis	2.11e-05	0.000545	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	2.08e-05	0.000537	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	2.08e-05	0.000537	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	2.03e-05	0.000525	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—RRM1—multiple sclerosis	2.02e-05	0.000522	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—BCHE—multiple sclerosis	1.9e-05	0.000492	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—GPC5—multiple sclerosis	1.9e-05	0.000491	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—RRM1—multiple sclerosis	1.86e-05	0.000481	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—RRM1—multiple sclerosis	1.84e-05	0.000476	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.6e-05	0.000415	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.6e-05	0.000415	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—RRM1—multiple sclerosis	1.58e-05	0.000407	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.57e-05	0.000405	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—BCHE—multiple sclerosis	1.54e-05	0.000397	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—BCHE—multiple sclerosis	1.51e-05	0.000389	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.47e-05	0.000379	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.43e-05	0.00037	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.35e-05	0.000348	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.23e-05	0.000317	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.23e-05	0.000317	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	1.22e-05	0.000316	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.22e-05	0.000314	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—BCHE—multiple sclerosis	1.16e-05	0.0003	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—APOE—multiple sclerosis	1.15e-05	0.000296	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	1.12e-05	0.000289	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.07e-05	0.000276	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—BCHE—multiple sclerosis	1.06e-05	0.000274	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	1.05e-05	0.000271	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—POMC—multiple sclerosis	9.84e-06	0.000254	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	9.57e-06	0.000247	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—APOE—multiple sclerosis	9.25e-06	0.000239	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—APOE—multiple sclerosis	9.06e-06	0.000234	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—BCHE—multiple sclerosis	9.05e-06	0.000234	CbGpPWpGaD
Methimazole—CYP2A6—Metabolism—ALB—multiple sclerosis	8.98e-06	0.000232	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—POMC—multiple sclerosis	7.94e-06	0.000205	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—POMC—multiple sclerosis	7.78e-06	0.000201	CbGpPWpGaD
Methimazole—CYP2B6—Metabolism—ALB—multiple sclerosis	7.24e-06	0.000187	CbGpPWpGaD
Methimazole—CYP2E1—Metabolism—ALB—multiple sclerosis	7.09e-06	0.000183	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—APOE—multiple sclerosis	6.99e-06	0.000181	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—BCHE—multiple sclerosis	6.98e-06	0.00018	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—APOE—multiple sclerosis	6.43e-06	0.000166	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—APOE—multiple sclerosis	6.37e-06	0.000165	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—POMC—multiple sclerosis	6e-06	0.000155	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—POMC—multiple sclerosis	5.52e-06	0.000143	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—POMC—multiple sclerosis	5.47e-06	0.000141	CbGpPWpGaD
Methimazole—CYP2C19—Metabolism—ALB—multiple sclerosis	5.47e-06	0.000141	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—APOE—multiple sclerosis	5.44e-06	0.000141	CbGpPWpGaD
Methimazole—CYP2D6—Metabolism—ALB—multiple sclerosis	5.03e-06	0.00013	CbGpPWpGaD
Methimazole—CYP2C9—Metabolism—ALB—multiple sclerosis	4.99e-06	0.000129	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—POMC—multiple sclerosis	4.68e-06	0.000121	CbGpPWpGaD
Methimazole—CYP1A2—Metabolism—ALB—multiple sclerosis	4.26e-06	0.00011	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—APOE—multiple sclerosis	4.2e-06	0.000109	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—POMC—multiple sclerosis	3.61e-06	9.33e-05	CbGpPWpGaD
Methimazole—CYP3A4—Metabolism—ALB—multiple sclerosis	3.29e-06	8.5e-05	CbGpPWpGaD
